Aquestive Therapeutics Newsroom

Aquestive Therapeutics: Promising FDA Feedback and Solid Foundation Support Buy Rating

TipRanksDec 2 10:35 ET · Ratings

Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 2 09:31 ET · Ratings

Aquestive Therapeutics Announces DA Feedback And Reaffirms NDA Submission Guidance For Anaphylm Sublingual Film; Confirms No Additional Adult Clinical Trials Are Necessary Prior To NDA Submission

BenzingaDec 2 08:59 ET

Aquestive Therapeutics Gains FDA Support for Anaphylm

TipRanksDec 2 08:28 ET

Express News | Aquestive Therapeutics Inc -Reaffirms New Drug Application (Nda) Q1 2025 Submission Guidance

ReutersDec 2 08:00 ET

Express News | Aquestive Therapeutics Inc -Confirms No Additional Adult Clinical Trials Are Necessary Prior to Nda Submission

ReutersDec 2 08:00 ET

Express News | Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms Nda Submission Guidance for Anaphylm™ (Epinephrine) Sublingual Film

ReutersDec 2 08:00 ET

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 13% Over the Past Week

Simply Wall StNov 29 08:30 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Aquestive Therapeutics: Strong Buy Rating Driven by Robust Revenue Performance and Strategic Positioning in Allergy Treatment

TipRanksNov 7 02:06 ET · Ratings

Aquestive Therapeutics Advances Drug Candidates Amid Challenges

TipRanksNov 6 16:40 ET

Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsNov 6 09:33 ET · Ratings

H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 6 06:31 ET · Ratings

Promising Future and Strategic Advancements: Buy Recommendation for Aquestive Therapeutics

TipRanksNov 6 06:25 ET

Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 5 16:36 ET · Conference Call

JMP Securities Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 5 12:31 ET · Ratings

Buy Rating Affirmed for Aquestive Therapeutics Amid Strong Product Pipeline and Financial Stability

TipRanksNov 5 11:45 ET · Ratings

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Yahoo FinanceNov 4 19:00 ET

Aquestive Therapeutics Optimistic Financial and Strategic Outlook

TipRanksNov 4 17:03 ET

Aquestive Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 4 16:50 ET · Announcements